Literature DB >> 12926026

Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves.

Dan T Simionescu1, Joshua J Lovekamp, Narendra R Vyavahare.   

Abstract

Glutaraldehyde-fixed porcine aortic valve tissues are widely used for heart valve replacement surgery in the form of bioprosthetic heart valves (BHVs). The durability of BHVs in the clinical setting is limited by tissue degeneration, mechanical failure, and calcification. BHVs rely on the putative ability of glutaraldehyde to render biologic tissues metabolically inert and fully resistant to enzymatic attack. In the present study, we detected and partially characterized the activity of collagen and elastin-degrading enzymes in unimplanted, glutaraldehyde-fixed porcine aortic cusp and wall tissues and compared enzyme activities with those extracted from fresh tissues. Active enzymes capable of degrading extracellular matrix were found to be present in soluble form as well as immobilized on glutaraldehyde-crosslinked tissue matrix. Total levels of collagenolytic activities were evaluated to approximately 0.25 microg of degraded collagen/mg of dry tissue/24 h for both glutaraldehyde-fixed wall and cusp tissues. A major finding of this study was the ability of soluble tissue enzymes to partially degrade glutaraldehyde-fixed collagen and particularly large amounts of glutaraldehyde-fixed elastin. These calcium-dependent gelatinases share many biochemical similarities with matrix metalloproteinases. These data strongly indicate that glutaraldehyde-fixed porcine valvular tissues are not metabolically inert and are not entirely resistant to enzymatic attack, thereby rendering BHVs vulnerable to biologic degeneration and subsequent chronic failure. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926026     DOI: 10.1002/jbm.a.10066

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  9 in total

1.  Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering.

Authors:  Mary E Tedder; Agneta Simionescu; Joseph Chen; Jun Liao; Dan T Simionescu
Journal:  Tissue Eng Part A       Date:  2010-09-06       Impact factor: 3.845

2.  Lectin and antibody-based histochemical techniques for cardiovascular tissue engineering.

Authors:  Agneta Simionescu; Mary E Tedder; Ting-Hsien Chuang; Dan T Simionescu
Journal:  J Histotechnol       Date:  2011-03       Impact factor: 0.714

3.  Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.

Authors:  Joshua J Lovekamp; Dan T Simionescu; Jeremy J Mercuri; Brett Zubiate; Michael S Sacks; Narendra R Vyavahare
Journal:  Biomaterials       Date:  2005-09-06       Impact factor: 12.479

4.  Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.

Authors:  Devanathan Raghavan; Dan T Simionescu; Naren R Vyavahare
Journal:  Biomaterials       Date:  2007-03-13       Impact factor: 12.479

Review 5.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

6.  Stabilized collagen scaffolds for heart valve tissue engineering.

Authors:  Mary E Tedder; Jun Liao; Benjamin Weed; Christopher Stabler; Henry Zhang; Agneta Simionescu; Dan T Simionescu
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

7.  Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.

Authors:  Dan T Simionescu; Joseph Chen; Michael Jaeggli; Bo Wang; Jun Liao
Journal:  J Healthc Eng       Date:  2012-06       Impact factor: 2.682

8.  Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage.

Authors:  Devanathan Raghavan; Barry C Starcher; Naren R Vyavahare
Journal:  Acta Biomater       Date:  2008-11-27       Impact factor: 8.947

9.  Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves.

Authors:  Devanathan Raghavan; Sagar R Shah; Naren R Vyavahare
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-01       Impact factor: 3.368

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.